HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN

Endocrinology

FDA approves teplizumab for delay of type 1 diabetes in patients 8 years and up

November 18, 2022

The US FDA announced the approval of teplizumab (Tzield), which is administered through IV infusion once daily for 14 consecutive days, for delaying the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 type 1 diabetes.

When puberty arrives too early or too late

October 09, 2021

Puberty will happen for every child, but when it arrives early or is delayed both parent and child may be worried. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition discussed typical reasons for both early and delayed pubertal development.